EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, IVBXF: Innovent Biologics Inc

15 Jan 2026
LAST:

11.17

CHANGE:
 0.30		OPEN:
11.17		HIGH:
11.17		ASK:
0.00		VOLUME:
200
CHG(%):
2.65		PREV:
11.47		LOW:
11.17		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
15 Jan 2611.1711.1711.1711.17200
14 Jan 2611.4711.4711.4711.47500
13 Jan 2610.9511.1510.9511.151.2K
12 Jan 2611.2411.5611.0011.563.3K
09 Jan 2611.1511.1511.1511.151.0K
08 Jan 2611.5511.5511.5511.55400
06 Jan 2611.0011.0011.0011.00200
05 Jan 2610.9010.9010.9010.90100
02 Jan 2610.8210.8210.3110.824.8K
31 Dec 2510.0010.109.759.75308.8K

PROFILE

Name:Innovent Biologics Inc
About:Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverematinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), Dupert (fulzerasib), DOVBLERON (taletrectinib), Jaypirca (pirtobrutinib), limertinib, and SYCUME (teprotumumab N01 injection). The company is also developing three new drugs, which are under regulatory review; four assets in Phase 3 and pivotal clinical trials; and 15 molecules in early clinical stage. In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People's Republic of China.
Sector:Healthcare
Industry:Biotechnology
Address:168 Dongping Street, Suzhou, China, 215123
Website:https://www.innoventbio.com
FIGI:BBG00PDF9MQ0

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:137.56 
Forward P/E:90.09 
Price to Sales:1.94 
Price to Book:10.45 
Revenue:11.423B 
EBITDA:1.302B 
Shares:1.709B 
Market Cap:19.088B 

TECHNICAL INDICATORS

MA5:11.301.2%
MA10:11.051.0%
MA20:10.813.3%
MA50:11.301.2%
MA100:11.876.3%
STO9:46.56
STO14:78.30
RSI14:60.29 
WPR14:-21.70
MTM14:0.94
ROC14:0.09 
ATR:0.40 
Week High:11.563.5%
Week Low:10.952.0%
Month High:11.563.5%
Month Low:9.75
Volatility:10.91